Phase I trial of CCX 507 in adult volunteers.

Trial Profile

Phase I trial of CCX 507 in adult volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Aug 2014

At a glance

  • Drugs CCX 507 (Primary)
  • Indications Inflammatory bowel diseases
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors ChemoCentryx
  • Most Recent Events

    • 12 Aug 2013 Positive safety data have been presented, according to a ChemoCentryx media release.
    • 22 May 2013 Status changed from recruiting to active, no longer recruiting, according to a ChemoCentryx media release.
    • 13 Mar 2013 Results are expected to be available in the second half of 2013, according to a ChemoCentryx media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top